Aprea Therapeutics, Inc.
APRE
$1.84
-$0.0799-4.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -39.95% | 15.93% | -18.08% | -6.47% | 35.84% |
| Total Depreciation and Amortization | -12.90% | 8.00% | 285.71% | 2,550.00% | 1,450.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 473.74% | -46.25% | 133.97% | -37.09% | -1.00% |
| Change in Net Operating Assets | 110.81% | -53.04% | 27.58% | -81.81% | -184.76% |
| Cash from Operations | 7.74% | 6.12% | -10.09% | -13.20% | -32.12% |
| Capital Expenditure | -- | 100.00% | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 100.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.63% | -- | -- | -- | 176.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.74% | -- | -- | -- | -98.78% |
| Cash from Financing | -99.62% | -- | -- | -- | 186.18% |
| Foreign Exchange rate Adjustments | 158.33% | -6,250.00% | 826.47% | 91.03% | -104.98% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -133.20% | 9.22% | -4.87% | -12.37% | 387.23% |